BioForce Nanosciences Holdings, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was USD 117,922 compared to USD 6,334 a year ago. Basic loss per share from continuing operations was USD 0.01. For the nine months, net loss was USD 158.285 million compared to USD 26,368 a year ago. Basic loss per share from continuing operations was USD 10.36.